| Kristin Marie Goodwin, | |
|
13400 E Shea Blvd, Scottsdale, AZ 85259-5452 | |
| (480) 301-8000 | |
| Not Available |
| Full Name | Kristin Marie Goodwin |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 13400 E Shea Blvd, Scottsdale, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669946935 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 7122 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kristin Marie Goodwin, 7050 Old Millstone Dr, Mechanicsville, VA 23111-4278 Ph: (804) 763-9684 | Kristin Marie Goodwin, 13400 E Shea Blvd, Scottsdale, AZ 85259-5452 Ph: (480) 301-8000 |
News Archive
Antidepressants are commonly prescribed for the treatment of depression, but many individuals do not experience symptom relief from treatment.
Luna Innovations Incorporated announced today that it has executed a Settlement Agreement with Hansen Medical, Inc. (NASDAQ: HNSN) resolving the outstanding litigation between the companies.
"Aid to the poorest countries is dropping because donors are becoming more 'risk averse,' according to a senior official from the Organization for Economic Cooperation and Development," The Guardian reports, noting that "OECD figures last week showed that official development assistance from rich countries fell by four percent in real terms last year, following a dip in 2011."
An increased risk of autism spectrum disorders (ASD) could result from an accumulation of many small, common genetic variations rather than large-effect, rare changes in the genetic code, according to a multicenter team led by researchers at the University of Pittsburgh School of Medicine.
Keryx Biopharmaceuticals, Inc. today announced that KRX-0401 (perifosine) has received Orphan-Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma. In August, the Company announced that it had reached an agreement with the FDA regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial in relapsed/refractory multiple myeloma and that the study is expected to start by year-end.
› Verified 7 days ago
Ms. Attria Batoon Honda, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 12000 N 90th T., Scottsdale, AZ 85260 Phone: 480-451-2033 | |
Jennifer Klaine, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1475 N Granite Reef Rd, Scottsdale, AZ 85257 Phone: 480-990-1904 | |
Jared Stuck, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 16413 N 91st St Bldg C145, Scottsdale, AZ 85260 Phone: 480-447-3262 Fax: 480-630-2066 | |
Emily Ludwig, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 13802 N Scottsdale Rd Ste 163, Scottsdale, AZ 85254 Phone: 480-401-1848 | |
Siyu Yi, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 7025 N Scottsdale Rd Ste 200, Scottsdale, AZ 85253 Phone: 602-385-8733 | |
Ms. Connie Sue Williams, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8115 E Indian Bend Rd, Ste 123, Scottsdale, AZ 85250 Phone: 480-951-6451 | |
Tonya Lee Soules, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8429 E Via De Jardin, Scottsdale, AZ 85258 Phone: 480-664-1266 |